Plasma phosphatidylcholine concentrations of polyunsaturated fatty acids are differentially associated with hip bone mineral density and hip fracture in older adults: The framingham osteoporosis study

Journal of Bone and Mineral Research

Volumn 27, Issue 5, 2012, Pages 1222-1230

  Farina, Emily K ^a   Kiel, Douglas P ^b   Roubenoff, Ronenn ^c   Schaefer, Ernst J ^a   Cupples, L Adrienne ^d   Tucker, Katherine L ^e  

^a TUFTS UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TUFTS UNIVERSITY   (United States)

^d BOSTON UNIVERSITY   (United States)

^e NORTHEASTERN UNIVERSITY   (United States)

Author keywords

ARACHIDONIC ACID; BMD; DOCOSAHEXAENOIC ACID; FRACTURE; LINOLEIC ACID

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; LINOLEIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE POLYUNSATURATED FATTY ACID; UNCLASSIFIED DRUG;

AGED; ARTICLE; BODY MASS; BONE DENSITY; FEMALE; FEMORAL NECK BONE MINERAL DENSITY; FOLLOW UP; HIP FRACTURE; HUMAN; MALE; SEX DIFFERENCE;

ADULT; AGED; BONE DENSITY; CROSS-SECTIONAL STUDIES; FATTY ACIDS, UNSATURATED; FEMALE; FOLLOW-UP STUDIES; HIP FRACTURES; HIP JOINT; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PHOSPHATIDYLCHOLINES; RISK FACTORS;

EID: 84859884311     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1581     Document Type: Article

References (66)

1. Watkins BA, Li Y, Seifert MF., Nutraceutical fatty acids as biochemical and molecular modulators of skeletal biology. J Am Coll Nutr. 2001; 20 (5 Suppl): 410S-6S; discussion 417S-20S.
2. Watkins BA, Li Y, Lippman HE, Seifert MF., Omega-3 polyunsaturated fatty acids and skeletal health. Exp Biol Med (Maywood). 2001; 226 (6): 485-97.
3. Kruger MC, Coetzee M, Haag M, Weiler H., Long-chain polyunsaturated fatty acids: selected mechanisms of action on bone. Prog Lipid Res. 2010; 49 (4): 438-49.
4. Salari P, Rezaie A, Larijani B, Abdollahi M., A systematic review of the impact of n-3 fatty acids in bone health and osteoporosis. Med Sci Monit. 2008; 14 (3): RA37-44.
5. Kettler DB., Can manipulation of the ratios of essential fatty acids slow the rapid rate of postmenopausal bone loss?. Altern Med Rev. 2001; 6 (1): 61-77.
6. Albertazzi P, Coupland K., Polyunsaturated fatty acids. Is there a role in postmenopausal osteoporosis prevention?. Maturitas. 2002; 42 (1): 13-22.
7. Krey G, Braissant O, L'Horset F, Kalkhoven E, Perroud M, Parker MG, Wahli W., Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol. 1997; 11 (6): 779-91.
8. Delerive P, De Bosscher K, Besnard S, Vanden Berghe W, Peters JM, Gonzalez FJ, Fruchart JC, Tedgui A, Haegeman G, Staels B., Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem. 1999; 274 (45): 32048-54.
9. Rosen ED, Sarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM., PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell. 1999; 4 (4): 611-7.
10. Lecka-Czernik B, Suva LJ., Resolving the Two "Bony" Faces of PPAR-gamma. PPAR Res. 2006; 2006: 27489.
11. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac RL., Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med. 2002; 196 (8): 1025-37.
12. Herrera BS, Ohira T, Gao L, Omori K, Yang R, Zhu M, Muscara MN, Serhan CN, Van Dyke TE, Gyurko R., An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorption. Br J Pharmacol. 2008; 155 (8): 1214-23.
13. Watkins BA, Li Y, Lippman HE, Feng S., Modulatory effect of omega-3 polyunsaturated fatty acids on osteoblast function and bone metabolism. Prostaglandins Leukot Essent Fatty Acids. 2003; 68 (6): 387-98.
14. Coetzer H, Claassen N, van Papendorp DH, Kruger MC., Calcium transport by isolated brush border and basolateral membrane vesicles: role of essential fatty acid supplementation. Prostaglandins Leukot Essent Fatty Acids. 1994; 50 (5): 257-66.
15. Buck AC, Davies RL, Harrison T., The protective role of eicosapentaenoic acid [EPA] in the pathogenesis of nephrolithiasis. J Urol. 1991; 146 (1): 188-94.
16. Baggio B, Budakovic A, Nassuato MA, Vezzoli G, Manzato E, Luisetto G, Zaninotto M., Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis. Kidney Int. 2000; 58 (3): 1278-84.
17. Baggio B, Gambaro G, Zambon S, Marchini F, Bassi A, Bordin L, Clari G, Manzato E., Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium nephrolithiasis. J Am Soc Nephrol. 1996; 7 (4): 613-20.
18. Rousseau JH, Kleppinger A, Kenny AM., Self-reported dietary intake of omega-3 fatty acids and association with bone and lower extremity function. J Am Geriatr Soc. 2009; 57 (10): 1781-8.
19. Weiss LA, Barrett-Connor E, von Muhlen D., Ratio of n-6 to n-3 fatty acids and bone mineral density in older adults: the Rancho Bernardo Study. Am J Clin Nutr. 2005; 81 (4): 934-8.
20. Kruger MC, Coetzer H, de Winter R, Gericke G, van Papendorp DH., Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis. Aging (Milano). 1998; 10 (5): 385-94.
21. Martin-Bautista E, Munoz-Torres M, Fonolla J, Quesada M, Poyatos A, Lopez-Huertas E., Improvement of bone formation biomarkers after 1-year consumption with milk fortified with eicosapentaenoic acid, docosahexaenoic acid, oleic acid, and selected vitamins. Nutr Res. 2010; 30 (5): 320-6.
22. Salari Sharif P, Asalforoush M, Ameri F, Larijani B, Abdollahi M., The effect of n-3 fatty acids on bone biomarkers in Iranian postmenopausal osteoporotic women: a randomized clinical trial. Age (Dordr). 2010; 32 (2): 179-86.
23. Griel AE, Kris-Etherton PM, Hilpert KF, Zhao G, West SG, Corwin RL., An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans. Nutr J. 2007; 6: 2.
24. Zwart SR, Pierson D, Mehta S, Gonda S, Smith SM., Capacity of omega-3 fatty acids or eicosapentaenoic acid to counteract weightlessness-induced bone loss by inhibiting NF-kappaB activation: from cells to bed rest to astronauts. J Bone Miner Res. 2010; 25 (5): 1049-57.
25. Hogstrom M, Nordstrom P, Nordstrom A., n-3 Fatty acids are positively associated with peak bone mineral density and bone accrual in healthy men: the NO2 Study. Am J Clin Nutr. 2007; 85 (3): 803-7.
26. Martinez-Ramirez MJ, Palma S, Martinez-Gonzalez MA, Delgado-Martinez AD, de la Fuente C, Delgado-Rodriguez M., Dietary fat intake and the risk of osteoporotic fractures in the elderly. Eur J Clin Nutr. 2007; 61 (9): 1114-20.
27. Virtanen JK, Mozaffarian D, Cauley JA, Mukamal KJ, Robbins J, Siscovick DS., Fish consumption, bone mineral density, and risk of hip fracture among older adults: the cardiovascular health study. J Bone Miner Res. 2010; 25 (9): 1972-9.
28. Orchard TS, Cauley JA, Frank GC, Neuhouser ML, Robinson JG, Snetselaar L, Tylavsky F, Wactawski-Wende J, Young AM, Lu B, Jackson RD., Fatty acid consumption and risk of fracture in the Women's Health Initiative. Am J Clin Nutr. 2010; 92 (6): 1452-60.
29. Dawber TR, Meadors GF, Moore FE Jr., Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health. 1951; 41 (3): 279-81.
30. Ma J, Folsom AR, Shahar E, Eckfeldt JH., Plasma fatty acid composition as an indicator of habitual dietary fat intake in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr. 1995; 62 (3): 564-71.
31. Dayton S, Hashimoto S, Dixon W, Pearce ML., Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. J Lipid Res. 1966; 7 (1): 103-111.
32. Schaefer EJ, Bongard V, Beiser AS, Lamon-Fava S, Robins SJ, Au R, Tucker KL, Kyle DJ, Wilson PW, Wolf PA., Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol. 2006; 63 (11): 1545-50.
33. Rose HG, Oklander M., Improved procedure for the extraction of lipids from human erythrocytes. J Lipid Res. 1965; 6: 428-31.
34. Patton GM, Fasulo JM, Robins SJ., Separation of phospholipids and individual molecular species of phospholipids by high-performance liquid chromatography. J Lipid Res. 1982; 23 (1): 190-6.
35. Schaefer EJ, Robins SJ, Patton GM, Sandberg MA, Weigel-DiFranco CA, Rosner B, Berson EL., Red blood cell membrane phosphatidylethanolamine fatty acid content in various forms of retinitis pigmentosa. J Lipid Res. 1995; 36 (7): 1427-33.
36. Hannan MT, Felson DT, Anderson JJ., Bone mineral density in elderly men and women: results from the Framingham osteoporosis study. J Bone Miner Res. 1992; 7 (5): 547-53.
37. Hannan MT, Felson DT, Dawson-Hughes B, Tucker KL, Cupples LA, Wilson PW, Kiel DP., Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res. 2000; 15 (4): 710-20.
38. Kiel DP, Mercier CA, Dawson-Hughes B, Cali C, Hannan MT, Anderson JJ., The effects of analytic software and scan analysis technique on the comparison of dual X-ray absorptiometry with dual photon absorptiometry of the hip in the elderly. J Bone Miner Res. 1995; 10 (7): 1130-6.
39. Kiel DP, Felson DT, Anderson JJ, Wilson PW, Moskowitz MA., Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med. 1987; 317 (19): 1169-74.
40. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE., Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985; 122 (1): 51-65.
41. Farina EK, Kiel DP, Roubenoff R, Schaefer EJ, Cupples LA, Tucker KL., Protective effects of fish intake and interactive effects of long-chain polyunsaturated fatty acid intakes on hip bone mineral density in older adults: The Framingham Osteoporosis Study. Am J Clin Nutr. 2011; 93 (5): 1142-51.
42. Castelao JE, Gago-Dominguez M., Risk factors for cardiovascular disease in women: relationship to lipid peroxidation and oxidative stress. Med Hypotheses. 2008; 71 (1): 39-44.
43. Nathan L, Chaudhuri G., Antioxidant and prooxidant actions of estrogens: potential physiological and clinical implications. Semin Reprod Endocrinol. 1998; 16 (4): 309-14.
44. Song JH, Miyazawa T., Enhanced level of n-3 fatty acid in membrane phospholipids induces lipid peroxidation in rats fed dietary docosahexaenoic acid oil. Atherosclerosis. 2001; 155 (1): 9-18.
45. Umegaki K, Hashimoto M, Yamasaki H, Fujii Y, Yoshimura M, Sugisawa A, Shinozuka K., Docosahexaenoic acid supplementation-increased oxidative damage in bone marrow DNA in aged rats and its relation to antioxidant vitamins. Free Radic Res. 2001; 34 (4): 427-35.
46. Graham LS, Parhami F, Tintut Y, Kitchen CM, Demer LL, Effros RB., Oxidized lipids enhance RANKL production by T lymphocytes: implications for lipid-induced bone loss. Clin Immunol. 2009; 133 (2): 265-75.
47. Macdonald HM, New SA, Golden MH, Campbell MK, Reid DM., Nutritional associations with bone loss during the menopausal transition: evidence of a beneficial effect of calcium, alcohol, and fruit and vegetable nutrients and of a detrimental effect of fatty acids. Am J Clin Nutr. 2004; 79 (1): 155-65.
48. Plourde M, Cunnane SC., Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab. 2007; 32 (4): 619-34.
49. Dichtl W, Ares MP, Jonson AN, Jovinge S, Pachinger O, Giachelli CM, Hamsten A, Eriksson P, Nilsson J., Linoleic acid-stimulated vascular adhesion molecule-1 expression in endothelial cells depends on nuclear factor-kappaB activation. Metabolism. 2002; 51 (3): 327-33.
50. Park HJ, Lee YW, Hennig B, Toborek M., Linoleic acid-induced VCAM-1 expression in human microvascular endothelial cells is mediated by the NF-kappa B-dependent pathway. Nutr Cancer. 2001; 41 (1-2): 126-34.
51. Weiler HA., Dietary supplementation of arachidonic acid is associated with higher whole body weight and bone mineral density in growing pigs. Pediatr Res. 2000; 47 (5): 692-7.
52. Blanaru JL, Kohut JR, Fitzpatrick-Wong SC, Weiler HA., Dose response of bone mass to dietary arachidonic acid in piglets fed cow milk-based formula. Am J Clin Nutr. 2004; 79 (1): 139-47.
53. Weiler H, Fitzpatrick-Wong S, Schellenberg J, McCloy U, Veitch R, Kovacs H, Kohut J, Kin Yuen C., Maternal and cord blood long-chain polyunsaturated fatty acids are predictive of bone mass at birth in healthy term-born infants. Pediatr Res. 2005; 58 (6): 1254-8.
54. Farina EK, Kiel DP, Roubenoff R, Schaefer EJ, Cupples LA, Tucker KL., Dietary intakes of arachidonic acid and alpha-linolenic acid are associated with reduced risk of hip fracture in older adults. J Nutr. 2011; 141 (6): 1146-53.
55. Delerive P, De Bosscher K, Vanden Berghe W, Fruchart JC, Haegeman G, Staels B., DNA binding-independent induction of IkappaBalpha gene transcription by PPARalpha. Mol Endocrinol. 2002; 16 (5): 1029-39.
56. Wang AC, Dai X, Luu B, Conrad DJ., Peroxisome proliferator-activated receptor-gamma regulates airway epithelial cell activation. Am J Respir Cell Mol Biol. 2001; 24 (6): 688-93.
57. Yu Y, Correll PH, Vanden Heuvel JP., Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism. Biochim Biophys Acta. 2002; 1581 (3): 89-99.
58. Tasaki Y, Takamori R, Koshihara Y., Prostaglandin D2 metabolite stimulates collagen synthesis by human osteoblasts during calcification. Prostaglandins. 1991; 41 (4): 303-13.
59. Koshihara Y, Takamori R, Nomura K, Sugiura S, Kurozumi S., Enhancement of in vitro mineralization in human osteoblasts by a novel prostaglandin A1 derivative TEI-3313. J Pharmacol Exp Ther. 1991; 258 (3): 1120-6.
60. Serhan CN, Yacoubian S, Yang R., Anti-inflammatory and proresolving lipid mediators. Annu Rev Pathol. 2008; 3: 279-312.
61. Serhan CN, Levy BD, Clish CB, Gronert K, Chiang N., Lipoxins, aspirin-triggered 15-epi-lipoxin stable analogs and their receptors in anti-inflammation: a window for therapeutic opportunity. Ernst Schering Res Found Workshop. 2000; (31): 143-85.
62. Serhan CN, Jain A, Marleau S, Clish C, Kantarci A, Behbehani B, Colgan SP, Stahl GL, Merched A, Petasis NA, Chan L, Van Dyke TE., Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol. 2003; 171 (12): 6856-65.
63. Hong S, Gronert K, Devchand PR, Moussignac RL, Serhan CN., Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J Biol Chem. 2003; 278 (17): 14677-87.
64. Willett WC., Nutritional epidemiology. 2nd ed. New York: Oxford University Press; 1998.
65. Ray NF, Chan JK, Thamer M, Melton LJ 3rd., Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res. 1997; 12 (1): 24-35.
66. Leibson CL, Tosteson AN, Gabriel SE, Ransom JE, Melton LJ., Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc. 2002; 50 (10): 1644-50.